The overexpression of ABCG2 has been found to confer MDR in multiple types of cancers including breast cancer (Mao and Unadkat, 2015), non-small cell lung cancer (Yoh et al., 2004) and acute myelogenous leukemia (Ross et al., 2000). This evidence concerns the gene ABCG2 and non-small cell lung carcinoma.